OBJECTIVE
We compared demographic and clinical characteristics between patients with late-onset (LO) and early-onset (EO) systemic lupus erythematosus (SLE) and examined their longitudinal associations with treatment targets and long-term outcomes, irreversible organ damage accrual and health-related quality of life (H...
W. Louthrenoo, A. Hoi, V. Golder et al.· Journal of Rheumatology· 0 citations
OBJECTIVES
To characterize clinical manifestations, major organ involvement, real-world treatment patterns, and factors associated with severity classification in Japanese patients with mixed connective tissue disease (MCTD), aiming to clarify its heterogeneous clinical spectrum.
METHODS
This nationwide retrospective...
S. Kubo, Yurie Kanda, Hideto Kameda et al.· Rheumatology· 0 citations
This review summarizes advances in SLE stratification based on immune phenotyping and multi-omics approaches and outlines emerging therapies, including biologics, intracellular inhibitors, and cell-based treatments.
Yurie Satoh-Kanda, S. Nakayamada, Yoshiya Tanaka· Expert Review of Clinical Im...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.